SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001102624-13-000291
Filing Date
2013-03-06
Accepted
2013-03-06 19:53:08
Documents
1
Period of Report
2013-03-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3204
  Complete submission text file 0001102624-13-000291.txt   4906
Mailing Address C/O AEOLUS PHARMACEUTICALS, INC. 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691
Business Address
McManus John L (Reporting) CIK: 0001193923 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50481 | Film No.: 13671273

Mailing Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691
Business Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691 9494819825
AEOLUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001261734 (see all company filings)

IRS No.: 561953785 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations